Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1994 Nov 1;180(5):1889–1900. doi: 10.1084/jem.180.5.1889

Humoral immune responses in CD40 ligand-deficient mice

PMCID: PMC2191723  PMID: 7964465

Abstract

Individuals with X-linked hyper-IgM syndrome fail to express functional CD40 ligand (CD40L) and, as a consequence, are incapable of mounting protective antibody responses to opportunistic bacterial infections. To address the role of CD40L in humoral immunity, we created, through homologous recombination, mice deficient in CD40L expression. These mice exhibited no gross developmental deficiencies or health abnormalities and contained normal percentages of B and T cell subpopulations. CD40L-deficient mice did display selective deficiencies in humoral immunity; basal serum isotype levels were significantly lower than observed in normal mice, and IgE was undetectable. Furthermore, the CD40L-deficient mice failed to mount secondary antigen- specific responses to immunization with a thymus-dependent antigen, trinitrophenol-conjugated keyhole limpet hemocyanin (TNP-KLH). By contrast, the CD40L-deficient mice produced antigen-specific antibody of all isotypes except IgE in response to the thymus-independent antigen, DNP-Ficoll. These results underscore the requirement of CD40L for T cell-dependent antibody responses. Moreover, Ig class switching to isotypes other than IgE can occur in vivo in the absence of CD40L, supporting the notion that alternative B cell signaling pathways regulate responses to thymus-independent antigens.

Full Text

The Full Text of this article is available as a PDF (2.8 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alderson M. R., Armitage R. J., Tough T. W., Strockbine L., Fanslow W. C., Spriggs M. K. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med. 1993 Aug 1;178(2):669–674. doi: 10.1084/jem.178.2.669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Andersson J., Schreier M. H., Melchers F. T-cell-dependent B-cell stimulation is H-2 restricted and antigen dependent only at the resting B-cell level. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1612–1616. doi: 10.1073/pnas.77.3.1612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Appleby P., Catty D. Transmission of immunoglobulin to foetal and neonatal mice. J Reprod Immunol. 1983 Jul;5(4):203–213. doi: 10.1016/0165-0378(83)90236-x. [DOI] [PubMed] [Google Scholar]
  4. Armitage R. J., Macduff B. M., Spriggs M. K., Fanslow W. C. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J Immunol. 1993 May 1;150(9):3671–3680. [PubMed] [Google Scholar]
  5. Armitage R. J., Maliszewski C. R., Alderson M. R., Grabstein K. H., Spriggs M. K., Fanslow W. C. CD40L: a multi-functional ligand. Semin Immunol. 1993 Dec;5(6):401–412. doi: 10.1006/smim.1993.1046. [DOI] [PubMed] [Google Scholar]
  6. Armitage R. J., Tough T. W., Macduff B. M., Fanslow W. C., Spriggs M. K., Ramsdell F., Alderson M. R. CD40 ligand is a T cell growth factor. Eur J Immunol. 1993 Sep;23(9):2326–2331. doi: 10.1002/eji.1830230941. [DOI] [PubMed] [Google Scholar]
  7. Broen J. J., Cafruny W. A. Immunoglobulin transfer from immune-reconstituted SCID mice to nursing neonates: blood distribution of antibody and association with perinatal virus protection. Reg Immunol. 1993 Jan-Feb;5(1):44–52. [PubMed] [Google Scholar]
  8. Brunswick M., Finkelman F. D., Highet P. F., Inman J. K., Dintzis H. M., Mond J. J. Picogram quantities of anti-Ig antibodies coupled to dextran induce B cell proliferation. J Immunol. 1988 May 15;140(10):3364–3372. [PubMed] [Google Scholar]
  9. Callard R. E., Armitage R. J., Fanslow W. C., Spriggs M. K. CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol Today. 1993 Nov;14(11):559–564. doi: 10.1016/0167-5699(93)90188-Q. [DOI] [PubMed] [Google Scholar]
  10. Chesnut R. W., Grey H. M. Studies on the capacity of B cells to serve as antigen-presenting cells. J Immunol. 1981 Mar;126(3):1075–1079. [PubMed] [Google Scholar]
  11. Cocks B. G., de Waal Malefyt R., Galizzi J. P., de Vries J. E., Aversa G. IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int Immunol. 1993 Jun;5(6):657–663. doi: 10.1093/intimm/5.6.657. [DOI] [PubMed] [Google Scholar]
  12. Doetschman T. C., Eistetter H., Katz M., Schmidt W., Kemler R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol. 1985 Jun;87:27–45. [PubMed] [Google Scholar]
  13. Fanslow W. C., Anderson D. M., Grabstein K. H., Clark E. A., Cosman D., Armitage R. J. Soluble forms of CD40 inhibit biologic responses of human B cells. J Immunol. 1992 Jul 15;149(2):655–660. [PubMed] [Google Scholar]
  14. Fanslow W. C., Clifford K. N., Seaman M., Alderson M. R., Spriggs M. K., Armitage R. J., Ramsdell F. Recombinant CD40 ligand exerts potent biologic effects on T cells. J Immunol. 1994 May 1;152(9):4262–4269. [PubMed] [Google Scholar]
  15. Foy T. M., Shepherd D. M., Durie F. H., Aruffo A., Ledbetter J. A., Noelle R. J. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J Exp Med. 1993 Nov 1;178(5):1567–1575. doi: 10.1084/jem.178.5.1567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Foy T. M., Waldschmidt T. J. Switching capacity of Fc epsilon RII-positive and -negative murine B cells. Eur J Immunol. 1993 Dec;23(12):3208–3216. doi: 10.1002/eji.1830231225. [DOI] [PubMed] [Google Scholar]
  17. Grabstein K. H., Maliszewski C. R., Shanebeck K., Sato T. A., Spriggs M. K., Fanslow W. C., Armitage R. J. The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2. J Immunol. 1993 Apr 15;150(8 Pt 1):3141–3147. [PubMed] [Google Scholar]
  18. Grabstein K. H., Park L. S., Morrissey P. J., Sassenfeld H., Price V., Urdal D. L., Widmer M. B. Regulation of murine T cell proliferation by B cell stimulatory factor-1. J Immunol. 1987 Aug 15;139(4):1148–1153. [PubMed] [Google Scholar]
  19. Harbury P. B., Zhang T., Kim P. S., Alber T. A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants. Science. 1993 Nov 26;262(5138):1401–1407. doi: 10.1126/science.8248779. [DOI] [PubMed] [Google Scholar]
  20. Haughton G., Arnold L. W., Whitmore A. C., Clarke S. H. B-1 cells are made, not born. Immunol Today. 1993 Feb;14(2):84–91. doi: 10.1016/0167-5699(93)90064-R. [DOI] [PubMed] [Google Scholar]
  21. Hirohata S., Jelinek D. F., Lipsky P. E. T cell-dependent activation of B cell proliferation and differentiation by immobilized monoclonal antibodies to CD3. J Immunol. 1988 Jun 1;140(11):3736–3744. [PubMed] [Google Scholar]
  22. Julius M. H., Rammensee H. G., Ratcliffe M. J., Lamers M. C., Langhorne J., Köhler G. The molecular interactions with helper T cells which limit antigen-specific B cell differentiation. Eur J Immunol. 1988 Mar;18(3):381–386. doi: 10.1002/eji.1830180310. [DOI] [PubMed] [Google Scholar]
  23. Katz D. H., Hamaoka T., Dorf M. E., Benacerraf B. Cell interactions between histoincompatible T and B lymphocytes. The H-2 gene complex determines successful physiologic lymphocyte interactions. Proc Natl Acad Sci U S A. 1973 Sep;70(9):2624–2628. doi: 10.1073/pnas.70.9.2624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lane P., Traunecker A., Hubele S., Inui S., Lanzavecchia A., Gray D. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur J Immunol. 1992 Oct;22(10):2573–2578. doi: 10.1002/eji.1830221016. [DOI] [PubMed] [Google Scholar]
  25. Maliszewski C. R., Grabstein K., Fanslow W. C., Armitage R., Spriggs M. K., Sato T. A. Recombinant CD40 ligand stimulation of murine B cell growth and differentiation: cooperative effects of cytokines. Eur J Immunol. 1993 May;23(5):1044–1049. doi: 10.1002/eji.1830230510. [DOI] [PubMed] [Google Scholar]
  26. Maliszewski C. R., Morrissey P. J., Fanslow W. C., Sato T. A., Willis C., Davison B. Delayed allograft rejection in mice transgenic for a soluble form of the IL-4 receptor. Cell Immunol. 1992 Sep;143(2):434–448. doi: 10.1016/0008-8749(92)90038-q. [DOI] [PubMed] [Google Scholar]
  27. Mansour S. L., Thomas K. R., Capecchi M. R. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature. 1988 Nov 24;336(6197):348–352. doi: 10.1038/336348a0. [DOI] [PubMed] [Google Scholar]
  28. McBurney M. W., Sutherland L. C., Adra C. N., Leclair B., Rudnicki M. A., Jardine K. The mouse Pgk-1 gene promoter contains an upstream activator sequence. Nucleic Acids Res. 1991 Oct 25;19(20):5755–5761. doi: 10.1093/nar/19.20.5755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Mond J. J., Brunswick M. A role for IFN-gamma and NK cells in immune responses to T cell-regulated antigens types 1 and 2. Immunol Rev. 1987 Oct;99:105–118. doi: 10.1111/j.1600-065x.1987.tb01174.x. [DOI] [PubMed] [Google Scholar]
  30. Mongini P. K., Stein K. E., Paul W. E. T cell regulation of IgG subclass antibody production in response to T-independent antigens. J Exp Med. 1981 Jan 1;153(1):1–12. doi: 10.1084/jem.153.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Noelle R. J., Roy M., Shepherd D. M., Stamenkovic I., Ledbetter J. A., Aruffo A. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6550–6554. doi: 10.1073/pnas.89.14.6550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Owens T. A noncognate interaction with anti-receptor antibody-activated helper T cells induces small resting murine B cells to proliferate and to secrete antibody. Eur J Immunol. 1988 Mar;18(3):395–401. doi: 10.1002/eji.1830180312. [DOI] [PubMed] [Google Scholar]
  33. Perlmutter R. M., Hansburg D., Briles D. E., Nicolotti R. A., Davie J. M. Subclass restriction of murine anti-carbohydrate antibodies. J Immunol. 1978 Aug;121(2):566–572. [PubMed] [Google Scholar]
  34. Peçanha L. M., Snapper C. M., Finkelman F. D., Mond J. J. Dextran-conjugated anti-Ig antibodies as a model for T cell-independent type 2 antigen-mediated stimulation of Ig secretion in vitro. I. Lymphokine dependence. J Immunol. 1991 Feb 1;146(3):833–839. [PubMed] [Google Scholar]
  35. Ramsdell F., Seaman M. S., Clifford K. N., Fanslow W. C. CD40 ligand acts as a costimulatory signal for neonatal thymic gamma delta T cells. J Immunol. 1994 Mar 1;152(5):2190–2197. [PubMed] [Google Scholar]
  36. Roy M., Waldschmidt T., Aruffo A., Ledbetter J. A., Noelle R. J. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J Immunol. 1993 Sep 1;151(5):2497–2510. [PubMed] [Google Scholar]
  37. Snapper C. M., McIntyre T. M., Mandler R., Pecanha L. M., Finkelman F. D., Lees A., Mond J. J. Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J Exp Med. 1992 May 1;175(5):1367–1371. doi: 10.1084/jem.175.5.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Snapper C. M., Mond J. J. Towards a comprehensive view of immunoglobulin class switching. Immunol Today. 1993 Jan;14(1):15–17. doi: 10.1016/0167-5699(93)90318-F. [DOI] [PubMed] [Google Scholar]
  39. Snapper C. M., Peçanha L. M., Levine A. D., Mond J. J. IgE class switching is critically dependent upon the nature of the B cell activator, in addition to the presence of IL-4. J Immunol. 1991 Aug 15;147(4):1163–1170. [PubMed] [Google Scholar]
  40. Spriggs M. K., Armitage R. J., Strockbine L., Clifford K. N., Macduff B. M., Sato T. A., Maliszewski C. R., Fanslow W. C. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J Exp Med. 1992 Dec 1;176(6):1543–1550. doi: 10.1084/jem.176.6.1543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Spriggs M. K., Koller B. H., Sato T., Morrissey P. J., Fanslow W. C., Smithies O., Voice R. F., Widmer M. B., Maliszewski C. R. Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6070–6074. doi: 10.1073/pnas.89.13.6070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Westendorf J. J., Ahmann G. J., Armitage R. J., Spriggs M. K., Lust J. A., Greipp P. R., Katzmann J. A., Jelinek D. F. CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line. J Immunol. 1994 Jan 1;152(1):117–128. [PubMed] [Google Scholar]
  43. Whalen B. J., Tony H. P., Parker D. C. Characterization of the effector mechanism of help for antigen-presenting and bystander resting B cell growth mediated by Ia-restricted Th2 helper T cell lines. J Immunol. 1988 Oct 1;141(7):2230–2239. [PubMed] [Google Scholar]
  44. Wortis H. H. Surface markers, heavy chain sequences and B cell lineages. Int Rev Immunol. 1992;8(2-3):235–246. doi: 10.3109/08830189209055576. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES